PCMT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.724400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.612200E-01
Normal-vs-Stage2
5.546200E-01
Normal-vs-Stage3
2.533400E-01
Normal-vs-Stage4
7.407600E-01
Stage1-vs-Stage2
8.427200E-01
Stage1-vs-Stage3
5.789200E-01
Stage1-vs-Stage4
7.119000E-01
Stage2-vs-Stage3
3.534600E-01
Stage2-vs-Stage4
7.540800E-01
Stage3-vs-Stage4
3.278600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.995000E-01
Normal-vs-AfricanAmerican
9.812800E-01
Normal-vs-Asian
2.840600E-01
Caucasian-vs-AfricanAmerican
7.388600E-01
Caucasian-vs-Asian
2.270800E-01
AfricanAmerican-vs-Asian
1.751990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.421600E-01
Normal-vs-Female
8.258400E-01
Male-vs-Female
6.966400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.984400E-01
Normal-vs-Age(41-60Yrs)
9.223400E-01
Normal-vs-Age(61-80Yrs)
6.438000E-01
Normal-vs-Age(81-100Yrs)
8.030000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.265400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.315600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.202600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.800000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.767200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.895200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.138800E-01
Normal-vs-Daily Drinker
1.631350E-01
Normal-vs-Weekly Drinker
7.106600E-01
Normal-vs-Occasional Drinker
6.678000E-01
Normal-vs-Social Drinker
6.923400E-01
Non Drinker-vs-Daily Drinker
4.555800E-01
Non Drinker-vs-Weekly Drinker
6.450600E-01
Non Drinker-vs-Occasional Drinker
7.579900E-02
Non Drinker-vs-Social Drinker
4.726600E-01
Daily Drinker-vs-Weekly Drinker
3.835600E-01
Daily Drinker-vs-Occasional Drinker
3.795900E-02
Daily Drinker-vs-Social Drinker
1.648770E-01
Weekly Drinker-vs-Occasional Drinker
2.036600E-01
Weekly Drinker-vs-Social Drinker
8.937000E-01
Occasional Drinker-vs-Social Drinker
1.748790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.140400E-01
Normal-vs-Grade 2
9.916000E-01
Normal-vs-Grade 3
9.947800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.986600E-01
Grade 1-vs-Grade 3
3.898200E-01
Grade 1-vs-Grade 4
8.140400E-01
Grade 2-vs-Grade 3
7.460800E-01
Grade 2-vs-Grade 4
9.916000E-01
Grade 3-vs-Grade 4
9.947800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.826400E-01
Normal-vs-NonDiabetic
7.501200E-01
Diabetic-vs-NonDiabetic
6.296000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.752400E-01
Normal-vs-NoPancreatitis
7.821200E-01
Pancreatitis-vs-NoPancreatitis
3.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.997400E-01
Normal-vs-N1
5.786000E-01
N0-vs-N1
1.693640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.341800E-01
Normal-vs-TP53-NonMutant
9.274000E-01
TP53-Mutant-vs-TP53-NonMutant
6.021400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
